Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
NCT01621100
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer Pain
Interventions
DRUG:
OROS hydromorphone
Sponsor
Janssen Korea, Ltd., Korea